key: cord-1011247-c1cap2rk
authors: Pan, Daniel; Sze, Shirley; Martin, Christopher A; Nevill, Clareece R; Minhas, Jatinder S; Divall, Pip; Nazareth, Joshua; Gray, Laura J; Khunti, Kamlesh; Abrams, Keith R; Nellums, Laura B; Pareek, Manish
title: COVID-19 and the new variant strain in England – What are the implications for those from ethnic minority groups?
date: 2021-03-18
journal: EClinicalMedicine
DOI: 10.1016/j.eclinm.2021.100805
sha: 996146e14101c6846c7a48c8460d1ad33b39cfcc
doc_id: 1011247
cord_uid: c1cap2rk

nan

Two new variants of Severe Acute Respiratory Distress Syndrome-Coronavirus-2 (SARS-CoV-2) have been reported over a matter of days in the United Kingdom (UK). The first variant, named VUI-202,012/01, originally detected in Kent and London, has an unusually large number of mutations that increase the virus' affinity for human hosts [1] . The second, named 501Y.V2 was first detected in Nelson Mandela Bay in South Africa [2] . Epidemiological evidence of a sharp rise in Coronavirus disease-2019 (COVID-19) admissions to both UK and South African hospitals along with a rising attributable proportion of cases due to these two variants, suggests that both are significantly more transmissible than previous variants.

Ethnic minority groups in the UK have been disproportionately affected by COVID-19 since the start of the pandemic [3] . A key driver in this association is the increased risk of infection [4] . The UK Office for National Statistics reported that Black and Asian men were more likely to work in occupations associated with higher COVID-19 death rates, such as taxi drivers, care home workers, and nurses. Ethnic minority groups are also more likely to live in deprived areas and in multi-generational households [5] . Without urgent action, the rapid spread of new, more transmissible variants will have even more disproportionate effects on these communities.

Meanwhile, Black and Asian groups continue to be under-represented in COVID-19 research and vaccine uptake. A report by the National Institute for Health Research found that ethnic minority groups only comprise 9.3% of participants in COVID-19 studies, and 5.7% in vaccine studies in particular, well below their representation in the national population (13.8%) [6] . This may be due to both structural and individual-level barriers to recruitment and participation. A qualitative survey exploring the views of ethnic minority communities towards participation in COVID-19 vaccine trials found that although there was broad agreement that clinical research was necessary, many were extremely uncomfortable with the idea of attending hospital, due to legitimate fears of contracting COVID-19, side effects of vaccines, and lack of support for language or cultural needs [7] . These barriers may be compounded by additional barriers such as fear, mistrust, privacy concerns, and inadequate provision of information.

In light of the worrying news about these more transmissible variants, we call for a focused effort to conduct more research on their transmission and outcomes in ethnic minority populations. This should be supported by meaningful engagement with these groups to inform research, policy, and practice [8] . We also call for protection of those from ethnic minority groups in the months to come. First, regularly updated public health messaging should be clear, accessible, and tailored to ethnic minority groups, to support the effectiveness of public health measures, alleviate anxiety, and increase trust in medical services. Culturally relevant documentation on vaccine ingredients, for example with proven halal certification, and consideration of religious and cultural engagements in research and vaccine schedules should be taken into account.

Second, a targeted, robust testing approach must be taken for groups who are at high risk of becoming infected. SARS-CoV-2 infection is associated with is poorly ventilated spaces, and with multiple household contacts [9] . Now is the time for the government to proactively provide the resources for public health teams to implement focused testing of districts where clusters of infection arise (which will inevitably disproportionately affect ethnic minority communities) rather than reconsider any plans for mass testing.

Third, ethnic minorities should be included as part of the decision making process for priority vaccination groups. Currently the UK's vaccination priority list focuses mainly on those who are at risk of severe disease, and apart from healthcare workers, give no mention to those at high risk of exposure to SARS-CoV-2 infection, such as ethnic minorities who make up the bulk of key worker roles. Through a balanced consideration of the risk of infection and the risk of death in the distribution of vaccines, a more equitable approach should be presented in the coming months. The first wave of COVID-19 has disproportionately affected ethnic minority groups resulting in poorer clinical outcomes in these communities; the new variant has the potential to worsen this further. We must learn from our experiences in 2020 and proactively include ethnic minority groups into public health policy.

COG-UK update on SARS-CoV-2 spike mutations of special interest

Confirmed cases of COVID-19 variant from South Africa identified in UK. 2020

Ethnicity and COVID-19: an urgent public health research priority

Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis

Office for National Statistics United Kingdom Government. Why have Black and South Asian people been hit hardest by COVID-19?

NIHR research ethnicity data provides insight on participation in COVID-19 studies

The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials

Putting the voices and insights of migrants and diverse ethnic groups at the centre of our response to COVID-19

SARS-CoV-2 transmission dynamics should inform policy